Mechanistic Model-Informed Discovery & Development Of Bispecific Antibodies For Immuno-Oncology

Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology

Modeling informed drug development

Fields Institute

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

U.S. Food and Drug Administration

The Model-Informed Drug Discovery and Development Program

Life Science Connect

ENM2020 - W33T1 - Mechanistic Models - c

A. Townsend Peterson

Session 1: Mechanistic Models - Jason Papin, PhD

Institute for Systems Biology

Keynote. Dr. Ted Rieger | JuliaCon 2019

The Julia Programming Language

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

U.S. Food and Drug Administration

MIDD Training Module 4 – Foundation to Model Informed Drug Development and Model Interconnectedness

U.S. Food and Drug Administration

How Can Model Informed Drug Development Impact Your Program?

MDS20 - Biologically-informed neural networks guide mechanistic modeling from sparse data

A Mechanistic Approach to Addiction: R&D Portfolio: Drug Discovery

Scripps Research

Mechanistic modeling can help switch from batch to continuous: Myth or Fact?

Pharmacometrics and model-informed precision dosing (MIPD)

COST ACTION ENOTTA

#Descriptive Vs #Mechanistic #Model by Dr Satish Polshettiwar

Dr Satish Polshettiwar sirs Educational Channel.

Development and Application of a Pediatric Mechanistic Kidney Model

Value Focused MIDD: Oncology Model-informed Drug Development Program

Drug Discovery of the Year - prize lecture

British Pharmacological Society

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

U.S. Food and Drug Administration

Tech Talk: The Joys and Perils of Leveraging Mechanistic Models in Health ML | Emily Fox

Women in Data Science Worldwide